Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Neuropathology and Applied Neurobiology|November 26, 2002
Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob diseaseA J E GreenBiochemical Society Transactions|August 28, 2002
Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob diseaseA J E GreenJournal of Immunological Methods|September 6, 2003
A specific ELISA for measuring neurofilament heavy chain phosphoformsA Petzold, G Keir, A J E Green, et al.Journal of Immunological Methods|April 22, 2004
An ELISA for glial fibrillary acidic proteinA Petzold, G Keir, A J E Green, et al.Perfusion|January 10, 2008
Evaluation of an alternative S100b assay for use in cardiac surgery: relationship with microemboli and neuropsychological outcomeD C Whitaker, A J E Green, J Stygall, et al.Neurology|January 10, 2002
Increased CSF levels of prostaglandin E(2) in variant Creutzfeldt-Jakob diseaseL Minghetti, F Cardone, A Greco, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2005
Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implicationsC A Goodall, M W Head, D Everington, et al.Neuroscience Letters|December 31, 2002
Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's diseaseA Petzold, R Jenkins, H C Watt, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 22, 2010
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year reviewG Chohan, C Pennington, J M Mackenzie, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 26, 2002
Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob diseaseB Van Everbroeck, A J E Green, E Vanmechelen, et al.Pageof 1